Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ogsen Gabrielyan"'
Autor:
Rolf Grempler, Michael Wolff, Eric Simon, Ramona Schmid, Claudia Eisele, Kathrin Rieber, Elke Fischer, Sonja Mettel, Ogsen Gabrielyan, Denis Delic, Gerd Luippold, Norbert Redeman
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197849 (2018)
BACKGROUND:Activation of the AMP-activated protein kinase (AMPK) is an attractive approach for the treatment of type 2 diabetes. AMPK activation reduces glucose levels in animal models of type 2 diabetes by increasing glucose uptake in skeletal muscl
Externí odkaz:
https://doaj.org/article/bfa740c560b542da8b31a64fd231e660
Autor:
Ines Jakob, Robert Sabat, Ramona Schmid, Christian T. Wohnhaas, Denis Delic, Franziska Wiech, Demetrios Christou, Patrick Baum, Kathrin Rieber, Manuela Griesser, Kerstin Wolk, Georgios Kokolakis, E. Witte‐Händel, Marcel Rolser, Ogsen Gabrielyan
Publikováno v:
Journal of Dermatological Science. 97:9-20
Background Psoriasis is a chronic inflammatory disease characterized by demarcated, raised, and scaling skin lesions. It often serves as a model for immune-mediated disorders. Gene expression profiling of affected skin has allowed insights into psori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7037c8f30b3be3f303086f7013a0c416
https://doi.org/10.1016/j.jdermsci.2019.11.003
https://doi.org/10.1016/j.jdermsci.2019.11.003
Autor:
Ogsen Gabrielyan, Heinz-Josef Lenz, Eric Van Cutsem, Alexey V. Salnikov, Ramona Schmid, T. Kitzing, Fortunato Ciardiello, Jürgen Braunger, Sabine Tejpar, Takayuki Yoshino, Guillem Argiles, Josef Höfler
Publikováno v:
Clinical colorectal cancer. 20(1)
INTRODUCTION: LUME-Colon 1 (NCT02149108) was a global, placebo-controlled phase III study of nintedanib in advanced colorectal cancer (CRC). Pre-specified biomarker analyses investigated the association of CRC consensus molecular subtypes (CMS) and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17f816c669b30e4b8ab22b4eeebf8735
https://pubmed.ncbi.nlm.nih.gov/33041226
https://pubmed.ncbi.nlm.nih.gov/33041226
Autor:
Franziska Wiech, Patrick Baum, Florian Gantner, Michael Mark, Marcel Rolser, Bernhard K. Krämer, Denis Delic, Oleg Tsuprykov, Richard Urquhart, Kathrin Rieber, Ahmed A. Hasan, Andreas Kohler, Ogsen Gabrielyan, Berthold Hocher, Thomas Klein
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Scientific Reports
Scientific Reports
Dipeptidyl peptidase 4 inhibitors and angiotensin II receptor blockers attenuate chronic kidney disease progression in experimental diabetic and non-diabetic nephropathy in a blood pressure and glucose independent manner, but the exact molecular mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9cd8b1ecb41eea4fa2e3268ffbdcc27
https://doi.org/10.1038/s41598-020-60336-4
https://doi.org/10.1038/s41598-020-60336-4
Autor:
Birgit Stierstorfer, Andre Broermann, Ramona Schmid, Claudia Eisele, Jochen Huber, Michael Wolff, Denis Delic, Ogsen Gabrielyan, Berthold Hocher, Patrick Baum, Ruediger Streicher, Marlene Sakowski, Bernhard K. Krämer, Sascha Keller
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 1
International Journal of Molecular Sciences, Vol 22, Iss 382, p 382 (2021)
Volume 22
Issue 1
International Journal of Molecular Sciences, Vol 22, Iss 382, p 382 (2021)
MicroRNAs (miRNAs) are short, non-coding RNA species that are important post-transcriptional regulators of gene expression and play an important role in the pathogenesis of non-alcoholic fatty liver disease. Here, we investigated the phosphodiesteras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebdfc471e363a368a6a803249daecff
https://doi.org/10.3390/ijms22010382
https://doi.org/10.3390/ijms22010382
Autor:
Denis Delic, Michael Wolff, Norbert Redeman, Claudia Eisele, Eric Simon, Gerd Luippold, Elke Fischer, Kathrin Rieber, Ogsen Gabrielyan, Ramona Schmid, Sonja Mettel, Rolf Grempler
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0197849 (2018)
PLoS ONE, Vol 13, Iss 5, p e0197849 (2018)
Background Activation of the AMP-activated protein kinase (AMPK) is an attractive approach for the treatment of type 2 diabetes. AMPK activation reduces glucose levels in animal models of type 2 diabetes by increasing glucose uptake in skeletal muscl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce31808b69ae631fc5de04bc908439d
https://doi.org/10.1371/journal.pone.0197849
https://doi.org/10.1371/journal.pone.0197849